View in EDS

Atezolizumab: an investigational agent for the treatment of biliary tract cancer.

Saved in:
Bibliographic Details
Title: Atezolizumab: an investigational agent for the treatment of biliary tract cancer.
Authors: Hack SP; Product Development (Oncology), Genentech Inc, South San Francisco, CA, USA., Zhu AX; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.
Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Oct; Vol. 30 (10), pp. 1007-1015. Date of Electronic Publication: 2021 Sep 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34459336
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atezolizumab: an investigational agent for the treatment of biliary tract cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hack+SP%22">Hack SP</searchLink>; Product Development (Oncology), Genentech Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+AX%22">Zhu AX</searchLink>; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2021 Oct; Vol. 30 (10), pp. 1007-1015. <i>Date of Electronic Publication: </i>2021 Sep 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34459336
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/13543784.2021.1974838
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1007
    Titles:
      – TitleFull: Atezolizumab: an investigational agent for the treatment of biliary tract cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hack SP
      – PersonEntity:
          Name:
            NameFull: Zhu AX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2021 Oct
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7658
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Expert opinion on investigational drugs
              Type: main
ResultId 1